久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Teva abandons Ajovy trial for cluster headaches pharmatimes
    April 24, 2019
    Teva has announced an update on its Ajovy (fremanezumab) clinical development for use in episodic cluster headache, after a Phase III study found that the primary endpoint for weekly average number of cluster headache attacks during the four-week treatmen
  • FDA Approves Device to Help Curb Cluster Headaches drugs.com
    April 20, 2017
    Cluster headaches, though rare, are among the most severe forms of headache a person can face.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service